Avadhanula Vasanthi, Agustinho Daniel Paiva, Menon Vipin Kumar, Chemaly Roy F, Shah Dimpy P, Qin Xiang, Surathu Anil, Doddapaneni Harshavardhan, Muzny Donna M, Metcalf Ginger A, Cregeen Sara Javornik, Gibbs Richard A, Petrosino Joseph F, Sedlazeck Fritz J, Piedra Pedro A
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Virus Evol. 2023 Dec 28;10(1):vead086. doi: 10.1093/ve/vead086. eCollection 2024.
Respiratory syncytial virus (RSV) infection in immunocompromised individuals often leads to prolonged illness, progression to severe lower respiratory tract infection, and even death. How the host immune environment of the hematopoietic stem cell transplant (HCT) adults can affect viral genetic variation during an acute infection is not understood well. In the present study, we performed whole genome sequencing of RSV/A or RSV/B from samples collected longitudinally from HCT adults with normal (<14 days) and delayed (≥14 days) RSV clearance who were enrolled in a ribavirin trial. We determined the inter-host and intra-host genetic variation of RSV and the effect of mutations on putative glycosylation sites. The inter-host variation of RSV is centered in the attachment (G) and fusion (F) glycoprotein genes followed by polymerase (L) and matrix (M) genes. Interestingly, the overall genetic variation was constant between normal and delayed clearance groups for both RSV/A and RSV/B. Intra-host variation primarily occurred in the G gene followed by non-structural protein (NS1) and L genes; however, gain or loss of stop codons and frameshift mutations appeared only in the G gene and only in the delayed viral clearance group. Potential gain or loss of O-linked glycosylation sites in the G gene occurred both in RSV/A and RSV/B isolates. For RSV F gene, loss of N-linked glycosylation site occurred in three RSV/B isolates within an antigenic epitope. Both oral and aerosolized ribavirin did not cause any mutations in the L gene. In summary, prolonged viral shedding and immune deficiency resulted in RSV variation, especially in structural mutations in the G gene, possibly associated with immune evasion. Therefore, sequencing and monitoring of RSV isolates from immunocompromised patients are crucial as they can create escape mutants that can impact the effectiveness of upcoming vaccines and treatments.
免疫功能低下个体的呼吸道合胞病毒(RSV)感染常导致病程延长、进展为严重的下呼吸道感染甚至死亡。造血干细胞移植(HCT)成年患者的宿主免疫环境如何在急性感染期间影响病毒基因变异,目前尚不清楚。在本研究中,我们对参与利巴韦林试验的、RSV清除正常(<14天)和延迟(≥14天)的HCT成年患者纵向采集的样本中的RSV/A或RSV/B进行了全基因组测序。我们确定了RSV的宿主间和宿主内基因变异以及突变对假定糖基化位点的影响。RSV的宿主间变异集中在附着(G)和融合(F)糖蛋白基因,其次是聚合酶(L)和基质(M)基因。有趣的是,RSV/A和RSV/B的正常清除组和延迟清除组之间的总体基因变异是恒定的。宿主内变异主要发生在G基因,其次是非结构蛋白(NS1)和L基因;然而,终止密码子的获得或缺失以及移码突变仅出现在G基因中,且仅出现在病毒清除延迟组中。G基因中O-连接糖基化位点的潜在获得或缺失在RSV/A和RSV/B分离株中均有发生。对于RSV F基因,在一个抗原表位内的三个RSV/B分离株中发生了N-连接糖基化位点的缺失。口服和雾化利巴韦林均未导致L基因发生任何突变。总之,病毒 shedding时间延长和免疫缺陷导致了RSV变异,尤其是G基因的结构突变,这可能与免疫逃逸有关。因此,对免疫功能低下患者的RSV分离株进行测序和监测至关重要,因为它们可能产生逃逸突变体,从而影响未来疫苗和治疗的有效性。